PHAR

Pharming Group NV

PHARMACEUTICAL PREPARATIONS
LIFE SCIENCES

Prices are adjusted according to historical splits.

Pharming Group NV Stock Price

Vitals

Today's Low:
$10.1300
Today's High:
$11.5000
Open Price:
$11.4000
52W Low:
$6.1
52W High:
$12.98
Prev. Close:
$11.4000
Volume:
19259

Company Statistics

Market Cap.:
$0.754 billion
Book Value:
3.01
Revenue TTM:
$0.204 billion
Operating Margin TTM:
18.2%
Gross Profit TTM:
$0.178 billion
Gross Profit TTM:
$0.178 billion
Profit Margin:
14.9%
Return on Assets TTM:
6.43%
Return on Equity TTM:
16.7%

Company Profile

Pharming Group NV had its IPO on 2020-12-23 under the ticker symbol PHAR.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Pharming Group NV has a staff strength of 0 employees.

Stock update

Shares of Pharming Group NV opened at $11.4 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $10.13 - $11.5, and closed at $11.4.

This is a 0% increase from the previous day's closing price.

A total volume of 19,259 shares were traded at the close of the day’s session.

In the last one week, shares of Pharming Group NV have increased by +14%.

Pharming Group NV's Key Ratios

Pharming Group NV has a market cap of $0.754 billion, indicating a price to book ratio of 3.714 and a price to sales ratio of 3.698.

In the last 12-months Pharming Group NV’s revenue was $0.204 billion with a gross profit of $0.178 billion and an EBITDA of $0.043 billion. The EBITDA ratio measures Pharming Group NV's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Pharming Group NV’s operating margin was 18.2% while its return on assets stood at 6.43% with a return of equity of 16.7%.

In Q3, Pharming Group NV’s quarterly earnings growth was a positive 208.9% while revenue growth was a positive 23.9%.

Pharming Group NV’s PE and PEG Ratio

Forward PE
149.25
Trailing PE
34.55
PEG
None

Its diluted EPS in the last 12-months stands at $0.33 per share while it has a forward price to earnings multiple of 149.25 and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Pharming Group NV’s profitability.

Pharming Group NV stock is trading at a EV to sales ratio of 3.311 and a EV to EBITDA ratio of 11.37. Its price to sales ratio in the trailing 12-months stood at 3.698.

Pharming Group NV stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Pharming Group NV ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Pharming Group NV ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Pharming Group NV’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Pharming Group NV's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Pharming Group NV paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$11.4
52-Week High
$12.98
52-Week Low
$6.1
Analyst Target Price
$None

Pharming Group NV stock is currently trading at $11.4 per share. It touched a 52-week high of $12.98 and a 52-week low of $12.98. Analysts tracking the stock have a 12-month average target price of $None.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Pharming Group NV

The stock symbol (also called stock or share ticker) of Pharming Group NV is PHAR

The IPO of Pharming Group NV took place on 2020-12-23

Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)

Last Price
Chg
Chg%
Alkermes Plc (ALKS)
$24.06
0.81
+3.48%
$143.23
-2.38
-1.63%
$2.14
-0.15
-6.38%
$0.84
-0.02
-1.81%
Ultragenyx (RARE)
$40.59
-1.34
-3.2%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Pharming Group NV, a specialty pharmaceutical company, develops products for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company is headquartered in Leiden, the Netherlands.

Address

DARWINWEG 24, LEIDEN, NL